Elevated P4HB expression in hepatocellular carcinoma and its role in UCA1-mediated malignant progression
Cellular Signalling · 2025
DOI: 10.1016/j.cellsig.2025.112131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2025. Verfasst von Song Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding, Procollagen-Proline Dioxygenase. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Jiangxi Provincial Natural Science Foundation, Jiangxi Provincial Department of Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, underscoring the urgent need for improved diagnostic and therapeutic strategies. In this study, we investigated the role of Prolyl 4-hydroxylase subunit beta (P4HB) in HCC progression and its potential as a diagnostic biomarker. Single-cell sequencing analysis revealed that P4HB is highly expressed in malignant HCC cell populations. Serum analysis demonstrated that P4HB levels were significantly elevated in HCC patients compared to healthy controls and those with benign liver diseases, with ROC analysis showing a high diagnostic performance, particularly when combined with alpha-fetoprotein (AFP). Functional assays, both in vitro and in vivo, confirmed that P4HB promotes the proliferation, migration, and invasion of HCC cells. Furthermore, we identified a novel interaction between P4HB and the lncRNA UCA1, which enhances glycolysis and malignant behavior in HCC cells. These findings suggest that P4HB is a promising biomarker for HCC diagnosis and a potential therapeutic target, particularly in the context of its interaction with UCA1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China.
- Department of Ophthalmology, Jiangxi Provincial People's Hospital, Nanchang 330006, Jiangxi, China.
- Vascular Access Outpatient Clinic, Nursing Department, The First Affiliated Hospital of Nanchang University, Nanchang 330008, Jiangxi, China.
- Department of Anesthesiology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China. Electronic address: lcmzxzz1314@163.com.
Förderung
- Jiangxi Provincial Natural Science Foundation
- Jiangxi Provincial Department of Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Huang, S., Cai, Y., Zhao, X., Du, X., & Hu, H. (2025). Elevated P4HB expression in hepatocellular carcinoma and its role in UCA1-mediated malignant progression. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112131
Vancouver
Huang S, Cai Y, Zhao X, Du X, Hu H. Elevated P4HB expression in hepatocellular carcinoma and its role in UCA1-mediated malignant progression. Cellular Signalling. 2025. doi:10.1016/j.cellsig.2025.112131
BibTeX
@article{Huang2025,
author = {Huang, Song and Cai, Yuehong and Zhao, Xueqing and Du, Xiaohong and Hu, Haijun},
title = {Elevated P4HB expression in hepatocellular carcinoma and its role in UCA1-mediated malignant progression},
journal = {Cellular Signalling},
year = {2025},
doi = {10.1016/j.cellsig.2025.112131}
}
EUVIMED